ATE335817T1 - Adhäsionsvarianten - Google Patents

Adhäsionsvarianten

Info

Publication number
ATE335817T1
ATE335817T1 AT97116064T AT97116064T ATE335817T1 AT E335817 T1 ATE335817 T1 AT E335817T1 AT 97116064 T AT97116064 T AT 97116064T AT 97116064 T AT97116064 T AT 97116064T AT E335817 T1 ATE335817 T1 AT E335817T1
Authority
AT
Austria
Prior art keywords
variants
adheson
adhesion
useful
adhesons
Prior art date
Application number
AT97116064T
Other languages
English (en)
Inventor
Daniel J Capon
Timothy J Gregory
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE335817T1 publication Critical patent/ATE335817T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT97116064T 1987-10-02 1988-10-03 Adhäsionsvarianten ATE335817T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10432987A 1987-10-02 1987-10-02

Publications (1)

Publication Number Publication Date
ATE335817T1 true ATE335817T1 (de) 2006-09-15

Family

ID=22299914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97116064T ATE335817T1 (de) 1987-10-02 1988-10-03 Adhäsionsvarianten

Country Status (4)

Country Link
EP (1) EP0832971B1 (de)
AT (1) ATE335817T1 (de)
DE (1) DE3856592T2 (de)
ZA (1) ZA887365B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1369128A1 (de) 2002-06-07 2003-12-10 Procorde GmbH Glycoprotein VI Inhibitoren und deren therapeutische Verwendung
US20070071744A1 (en) 2002-06-07 2007-03-29 Gotz Munch Agents which bind to epitopes of glycoprotein VI
US7531178B2 (en) 2002-06-07 2009-05-12 Trigen Gmbh Immunoadhesin comprising a glycoprotein VI domain
PT2222697E (pt) 2007-11-01 2013-02-15 Perseid Therapeutics Llc Polipeptídeos imunossupressores e ácidos nucleicos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110906A (en) * 1986-08-21 1992-05-05 The Trustees Of Columbia University In The City Of New York Derivatives of soluble T-4
JP3134874B2 (ja) * 1986-08-21 2001-02-13 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク Ｔ細胞表面タンパク質ｔ４をコードするｄｎａ並びにｔ４フラグメントのａｉｄｓ治療への使用
WO1988007376A1 (fr) * 1987-03-27 1988-10-06 Hiroshi Okajima Medicament contre les maladies virales
WO1989001940A1 (en) * 1987-09-04 1989-03-09 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
IL87902A0 (en) * 1987-10-08 1989-03-31 Dana Farber Cancer Inst Inc Soluble human cd4 fragments and applications thereof
WO1989003221A1 (en) * 1987-10-13 1989-04-20 Genelabs Incorporated Antisyncytial agent
PT88783B (pt) * 1987-10-23 1993-01-29 Smithkline Beckman Corp Processo de purificacao de proteina t4 soluvel e de producao da mesma
PT89484B (pt) * 1988-01-22 1994-03-31 Gen Hospital Corp Genes clonados codificadores de proteinas de fusao ig-cd4 e sua utilizacao
AU3006789A (en) * 1988-02-24 1989-08-24 Smithkline Beckman Corporation Expression of hiv binding proteins

Also Published As

Publication number Publication date
DE3856592D1 (de) 2006-09-21
EP0832971B1 (de) 2006-08-09
DE3856592T2 (de) 2007-10-04
EP0832971A1 (de) 1998-04-01
ZA887365B (en) 1990-05-30

Similar Documents

Publication Publication Date Title
ATE166387T1 (de) Adhäsionsvarianten
EP0259475A4 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
EP1017797A4 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
ATE358176T1 (de) Menschliche dnase
MY102472A (en) Preparation of funtional human urokinase proteins.
DE3751751D1 (de) Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
DK113389D0 (da) Monoklonale antistoffer
ES2168273T3 (es) Ligando para el receptor c-kit y metodos de uso del mismo.
ES2010727A6 (es) Metodo para producir lineas celulares que producen anticuerpos monoclonales reactivos frente a determinantes antigenicos de gp110 o de p25 de hiv.
NO177716C (no) Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
DK336688A (da) Nucleosider od fremgangsmaade til fremstilling deraf
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
FI913818A0 (fi) Nytt trombolytiskt aemne.
DE3856592D1 (de) Adhäsionsvarianten
ES2180550T3 (es) Moleculas receptoras de la hormona de glycoproteina.
NO933423D0 (no) Modifisert blodplate-faktor-4
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
ATE260339T1 (de) Antikörper gegen menschliches restrictin
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
Kotkes et al. New approaches to the characterization and isolation of migration inhibitory factor (MIF)
FR2606033B1 (fr) Proteine cytoplasmique des cellules suprabasales de l'epiderme, anticorps capables de reconnaitre cette proteine, et lignees cellulaires hybrides capables de secreter de tels anticorps
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
IT8647992A0 (it) Metodo per il trattamento di malattie autoimmunitarie,basato sull'uso del bendazac e di altri farmaci che inibiscono specificamente i processi di denaturazione proteica responsabili della reazione autoimmunitaria

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0832971

Country of ref document: EP

EELA Cancelled due to lapse of time